Download Topic Format Resources Weblink Medication-Assisted

MU-ADEPT Level 3: Advanced Training Resources
Topic
Format
Weblink
On-line course
The ATTC's Medication-Assisted Treatment with Special Populations online training,
http://www.attcelearn.org/
developed for both non-physician treatment providers and physicians, is designed to enhance
professionals' knowledge and skills related to reaching and educating the special populations
about MAT and increasing the use of MAT among minority populations.
Essays
A compilation of essays by individuals supported by Medication-Assisted Treatment in long- http://www.integration.samhsa.gov/clinicalterm recovery developed in partnership with Faces & Voices of Recovery and the National
practice/2011essaybook_FL.pdf
Alliance for Medication Assisted Recovery.
The Psychotherapeutic Medications Booklet and Database are designed as a "desk-top
http://www.findrxinformation.org/
reference" of medications commonly used to treat individuals with alcohol, drug, and mental
health conditions. This searchable database offers is intended to provide a basic understanding
of medication dose, frequency, side effects, emergency conditions, abuse potential, cautions,
and considerations for pregnant women.
Medication-Assisted
Treatment
Database/manual
Managing Opioid Abuse, Dependence, and Addiction in a Primary Care Setting, a
presentation by Jean J. Bonhomme MD, MPH, assistant professor, Morehouse School of
Medicine’s Department of Psychiatry, provides an introduction to opioid abuse for primary
care professionals
Prescribers’ Clinical Support System for Opioid Therapies (PCSS-O) is a collaborative project
that includes: American Academy of Addiction Psychiatry, American Dental Association,
American Medical Association, American Osteopathic Academy of Addiction Medicine,
American Psychiatric Association, American Society for Pain Management Nursing, and
International Nurses Society on Addictions. Site includes online modules (PowerPoints) and
archived webinars.
http://www.integration.samhsa.gov/clinicalpractice/Managing_Opiod_abuse,_dependence.pdf
Presentation
A Review of Considerations in the Assessment and Treatment of Pain and Risk for Opioid
Misuse by By Elinore F. McCance-Katz, MD, PhD, Medical Director, PCSS-O
http://www.pcsso.org/sites/default/files/Considerations%20in%20Assessment%20
and%20Treatment%20of%20Pain%20and%20Opioid%20Use%20Ri
sk%20%5BCompatibility%20Mode%5D.pdf
Manual
GroupHealth Chronic Opioid Therapy (COT) Safety Guideline For Patients With Chronic Non- http://www.ghc.org/all-sites/guidelines/chronicOpioid.pdf
Cancer Pain
Manual
SAMHSA’s Advisory: An Introduction to Extended-Release Injectable Naltrexone for the
Treatment of People with Opioid Dependence overviews extended-release injectable
naltrexone (Vivitrol), a treatment for people with opioid dependence, and discusses how it
differs from other medication-assisted treatments, safety concerns, and consumers most likely
to benefit from this treatment.
Medication-Assisted Treatment for Opioid Addiction: Friends and Families is a useful
resource developed by SAMHSA for friends and families of individuals struggling with
addiction.
SAMHSA’s Treatment Improvement Protocol (TIP) 40: Clinical Guidelines for the Use of
Buprenorphine in the Treatment of Opioid Addiction provides information that physicians can
use to make practical and informed decisions about the use of buprenorphine to treat opioid
addiction.
KAP Keys Based on TIP 40 Clinical Guidelines for the Use of Buprenorphine in the Treatment
of Opioid Addiction - includes: Dosage Forms of Buprenorphine Available in the United States
(as of July 2004), Drug Interactions, Components of a Complete Substance Abuse Assessment,
Recommended Baseline Laboratory Evaluation of Patients Who Are Addicted to Opioids, Signs
of Opioid Intoxication and Withdrawal, Staging and Grading Opioid Withdrawal, Assessing
Appropriateness for Buprenorphine Treatment, Treatment Protocols (Induction, Day 2
Forward, Stabilization), Patient Management
Presentation
Website
Management of
chronic nonterminal pain with
opioids
Resources
Management of
opioid addiction
Fact Sheet
Manual
Pocket Cards
http://www.pcss-o.org/
http://www.integration.samhsa.gov/Intro_To_Injectable_Naltrexo
ne.pdf
http://store.samhsa.gov/product/Medication-Assisted-Treatmentfor-Opioid-Addiction-Facts-for-Families-and-Friends/SMA09-4443
http://www.ncbi.nlm.nih.gov/books/NBK64245/
http://kap.samhsa.gov/products/tools/keys/pdfs/KK_40.pdf
Manual
SAMHSA’s TIP 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment http://www.ncbi.nlm.nih.gov/books/NBK64164/
Programs discusses MAT use in addiction treatment programs for opioid dependence
Booklet
Quick Guide Based on TIP 43 Medication-Assisted Treatment for Opioid Addiction in Opioid http://kap.samhsa.gov/products/tools/cl-guides/pdfs/QGC_43.pdf
Treatment Programs
KAP Keys Based on TIP 43 Medication-Assisted Treatment for Opioid Addiction in Opioid
http://kap.samhsa.gov/products/tools/keys/pdfs/KK_43.pdf
Treatment Programs - includes: Information Obtained About and Provided to Patients During
Screening and Admission, Pharmacotherapeutic Medications for Opioid Addiction Treatment,
Possible Side Effects of Opioid Agonist and Partial Agonist Therapy, Reported Drug Interactions
With Methadone, Strategies To Prevent or Minimize Harmful Drug Interactions in MAT,
Medications/Substances That Alter Opioid Medication Levels in the Body, Criteria for TakeHome Medications and Maximum Take-Home Dose, Patient Counseling in MAT, Common
Topics for Patient Educational Sessions in MAT, Characteristics of a Treatment Plan and a
Multidisciplinary Team, Associated Medical Problems, Hepatitis C Evaluation Flowchart, Cutoff
Concentrations and Detection Times for Substances of Abuse, Urine Drug Testing Guidelines,
Common Immunoassays Used in Drug Testing, Frequently Used Substance Combinations and
Common Reasons for Use, Common Medical and Obstetrical Compli cations Among Pregnant
Women, Laboratory Tests for Pregnant Women Who Are Opioid Addicted
Pocket Cards
Presentation
Review of Opioids and Treatment of Opioid Dependence. By Elinore F. McCance-Katz, MD,
PhD, Medical Director, PCSS-O
http://www.pcsso.org/sites/default/files/Review%20of%20Opioids%20and%20Tre
atment%20of%20Opioid%20Dependence.pdf
Patient Education The Facts about Naltrexone for Treatment of Opioid Dependence patient education brochure http://www.kap.samhsa.gov/products/brochures/pdfs/naltrexone
_facts.pdf
Brochure
Training/Presentati NIDA/ATTC Blending Initiative - Buprenorphine Treatment: Training for Multidisciplinary
http://www.attcnetwork.org/explore/priorityareas/science/blendi
Addiction Professionals
on
nginitiative/buptx/product_materials.asp
Training/Presentati
http://www.attcnetwork.org/explore/priorityareas/science/blendi
NIDA/ATTC Blending Initiative -Prescription Opioid Addiction Treatment Study (POATS)
nginitiative/poats/
on
Manual
TIP 54: Managing Chronic Pain in Adults With or in Recovery from Substance Use Disorders
equips clinicians with practical guidance and tools for treating chronic pain in adults with
substance use disorders. This TIP includes information and resources on patient assessment,
talking with patients about medication supply, addiction behaviors, opiod misuse measures,
and pain treatment agreements.
Manual
TIP 45 Detoxification and Substance Abuse Treatment educates clinicians about detoxification http://store.samhsa.gov/product/TIP-45-Detoxification-andand withdrawal.
Substance-Abuse-Treatment/SMA08-4131
Booklet
Quick Guide Based on TIP 45 Detoxification and Substance Abuse Treatment
Pocket Cards
KAP KEYS Based on TIP 45 Detoxification and Substance Abuse Treatment - includes:
http://kap.samhsa.gov/products/tools/keys/pdfs/KK_45.pdf
Intoxication and Withdrawal (Fact Facts, Symptoms, Management) From Cocaine,
Methamphetamine, and Other Stimulants, Alcohol, Herion and Other Opioids, Cannabis, Other
Drugs; Initial Evaluation Domains, Recommended Areas for Assessment to Determine
Appropriate Rehabilitation Plans, Commonly Abused Inhalants (Fact Facts, Symptoms,
Management)
Manual, Booklet,
Pocket Cards
See TIP 45 Detoxification and Substance Abuse Treatment Products
Article/Practice
Guideline
Mayo-Smith et al. for the Working Group on the Management of Alcohol Withdrawal Delirium, http://archinte.jamanetwork.com/article.aspx?articleid=217165
Practice Guidelines Committee, American Society of Addiction Medicine. Management of
Alcohol Withdrawal Delirium: An Evidence-Based Practice Guideline, Arch Intern Med.
2004;164:1405-1412
Saitz, R. Introduction to Alcohol Withdrawal. Alc Hlth Res World. 1998;22:5-12. (includes
http://pubs.niaaa.nih.gov/publications/arh22-1/05-12.pdf
CIWA assessment tool and dosing guidelines)
Treating pain in a
patient on chronic
opioid replacement
therapy (methadone
or buprenorphine)
Withdrawal and
detoxification
Pharmacotherapy of
alcohol withdrawal
Article
Pharmacotherapy of
opioid withdrawal
See TIP 45 Detoxification and Substance Abuse Treatment Products
Manual, Booklet,
Pocket Cards
Manual, Booklet,
Pocket Cards
Training/Presentati
on
See TIP 40 Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid
Addiction Products
See TIP 43 Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment
Programs Products
Manual
SAMHSA’s TIP 49: Incorporating Alcohol Pharmacotherapies into Medical Practice provides
guidance on implementing alcohol medications into routine medical practice.
http://kap.samhsa.gov/products/manuals/tips/pdf/TIP49.pdf
Booklet
Quick Guide For Physicians Based on TIP 49 Incorporating Alcohol Pharmacotherapies Into
Medical Practice
KAP Keys Based on TIP 49 Incorporating Alcohol Pharmacotherapies Into Medical Practice includes: medication facts, dosing, side effects, adverse reactions and their management;
Patient Management
NIAAA's Medical Management Treatment Manual: A Clinical Guide for Researchers and
Clinicians Providing Pharmacotherapy for Alcohol Dependence (Generic Version; 2010
edition) by Helen M. Pettinati, PhD and Margaret E. Mattson, PhD
http://kap.samhsa.gov/products/tools/cl-guides/pdfs/QGP_49.pdf
Booklet
SAMHSA's Pharmacologic Guidelines for Treating Individuals with Post-Traumatic Stress
Disorder and Co-Occurring Opioid Use Disorders offers guidelines for medication-assisted
treatment for individuals with post-traumatic stress disorder (PTSD) and co-occurring opioid
use disorders. Covers screening, concomitant treatment, pharmacotherapy, and multiple
substances of abuse.
http://store.samhsa.gov/product/Pharmacologic-Guidelines-forTreating-Individuals-with-Post-Traumatic-Stress-Disorder-and-CoOccurring-Opioid-Use-Disorders/SMA124688?WT.ac=EB_20120614_SMA12-4688
Article
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC181171/pdf/i1523Arikian, SR, Gorman, JM. A Review of the Diagnosis, Pharmacologic Treatment, and Economic 5998-003-03-0110.pdf
Aspects of Anxiety Disorders. Prim Care Companion J Clin Psychiatry. 2001; 3(3): 110–117.
Webinar
SBIRT and Tobacco Training Module is a webinar developed by HealthTeamWorks for the
http://healthteamworks.biz/sbirt-training/player.html
Colorado SBIRT project that provides practical information for providers seeking to implement
SBIRT and tobacco screening into routine practice. In addition to overviews of tobacco
screenings and SBIRT, the 1-hour webinar includes information on financing, brief
interventions, and referrals to treatment. 52 minutes.
Pocket Cards
Manual
Management of
tobacco addiction,
including
pharmacotherapies
http://kap.samhsa.gov/products/tools/cl-guides/pdfs/QGP_45.pdf
Manual, Booklet,
Pocket Cards
Pharmacotherapy of
alcohol dependence
Management of
anxiety disorders in
patients with
addictions
http://store.samhsa.gov/product/TIP-54-Managing-Chronic-Painin-Adults-With-or-in-Recovery-From-Substance-UseDisorders/SMA12-4671?WT.ac=EB_20120216_SMA12-4671
NIDA/ATTC Blending Initiative - Short-Term Opioid Withdrawal Using Buprenorphine:
Findings and Strategies from a NIDA Clinical Trials Network (CTN) Study
http://www.attcnetwork.org/explore/priorityareas/science/blendi
nginitiative/bupdetox/
http://kap.samhsa.gov/products/tools/keys/pdfs/KK_49.pdf
http://pubs.niaaa.nih.gov/publications/MedicalManual/MMManu
al.pdf
Booklet, Quick
Reference Guide,
Presentations
Basic and Advanced
skills for effective
motivational
interviewing
Mid-Atlantic ATTC’s Motivational Interviewing Website
http://www.motivationalinterview.org/
On-line course
Mid-Atlantic ATTC’s On-line course: "Foundations of Motivational Interviewing - Part I" 10
contact hours
Mid-Atlantic ATTC’s On-line course: "Foundations of Motivational Interviewing - Part II” 10
contact hours:
TIP 35 manual: Enhancing Motivation for Change in Substance Abuse Treatment
http://attcnetwork.org/regcenters/distanceeducation.asp?rcid=6
&content=DISTANCEED
http://attcnetwork.org/regcenters/distanceeducation.asp?rcid=6
&content=DISTANCEED
http://store.samhsa.gov/product/TIP-35-Enhancing-Motivationfor-Change-in-Substance-Abuse-Treatment/SMA08-4212
Booklet
Quick Guide Based on TIP 35 Enhancing Motivation for Change in Substance Abuse
Treatment
http://kap.samhsa.gov/products/tools/cl-guides/pdfs/QGC_35.pdf
Pocket Cards
KAP KEYS Based on TIP 35 Enhancing Motivation for Change in Substance Abuse Treatment - http://kap.samhsa.gov/products/tools/keys/pdfs/KK_35.pdf
includes: the FRAMES approach, Appropriate Motivational Strategies for Each Stage of Change,
Ten Effective Catalysts for Change, Four Types of Client Resistance, Change Plan Worksheet,
Deciding To Change,
Manual
TIP 24 A Guide to Substance Abuse Services for Primary Care Clinicians - Recommends
http://store.samhsa.gov/product/TIP-24-Guide-to-Substanceguidelines for primary care clinicians to follow in caring for patients with alcohol abuse and
Abuse-Services-for-Primary-Care-Clinicians/SMA08-4075
drug abuse problems. Discusses screening, assessment, brief intervention, medication-assisted
treatment, and legal issues of patient confidentiality.
Pocket Cards
KAP KEYS Based on TIP 24 A Guide to Substance Abuse Services for Primary Care Clinicians - http://kap.samhsa.gov/products/tools/keys/pdfs/KK_24.pdf
includes: Interview Approaches Based on the Patient's Readiness for Behavioral Change,
Michigan Alcoholism Screening Test, DSM-IV Diagnostic Criteria for Substance Abuse, TWEA K
Test (alcohol screener for pregnant women)
Manual
SAMHSA’s TIP 42: Substance Abuse Treatment for Persons With Co-Occurring Disorders
provides substance abuse providers with updated information on co-occurring substance use
and mental disorders and advances in treatment for these individuals. TIP 42 discusses
terminology, assessment, and treatment strategies and models.
http://store.samhsa.gov/product/TIP-42-Substance-AbuseTreatment-for-Persons-With-Co-Occurring-Disorders/SMA08-3992
Pocket Cards
KAP KEYS Based on TIP 42 Substance Abuse Treatment for Persons With Co-Occurring
Disorders - includes: Assessment for Co-Occurring Disorders, Motivational Enhancement
Approaches, Engagement Interventions, Key Questions in a Suicide Risk Review, Residential
Interventions, Borderline Personality Disorder–Step Work Handout, Antisocial Thinking-Error
Work
SAMHSA's General Principles for the Use of Pharmacological Agents To Treat Individuals
With Co-Occurring Mental and Substance Use Disorders provides general principles to assist
in the planning, delivery, and evaluation of pharmacologic approaches to support the recovery
of individuals with co-occurring mental and substance use disorders.
http://kap.samhsa.gov/products/tools/keys/pdfs/KK_42.pdf
Manual
Integrated
treatment for cooccurring substance
abuse and mental
illness
http://www.ahrq.gov/path/tobacco.htm
Website
On-line course
Working with
counselors: A team
approach to
addressing
substance use
disorders
Treating Tobacco Use and Dependence: 2008 Update, sponsored by the Public Health Service,
includes new, effective clinical treatments for tobacco dependence that have become available
since the 2000 Guideline was published. This update will make an important contribution to
the quality of care in the United States and to the health of the American people.
Booklet
http://store.samhsa.gov/product/General-Principles-for-the-Useof-Pharmacological-Agents-to-Treat-Individuals-with-Co-OccurringMental-and-Substance-Use-Disorders/SMA124689?WT.ac=EB_20120607_SMA12-4689
Webinar
NIAAA's Adolescent Development and Alcohol Use by Vivian B. Faden, Ph.D., Acting Director, http://www.niaaa.nih.gov/publications/presentations-andOffice of Science Policy and Communications, and Patricia A. Powell, Ph.D., Chief, Science
videocasts
Policy Branch. National Institute on Alcohol Abuse and Alcoholism, NIH. December 9, 2008
Manual
NIAAA's Alcohol Screening and Brief Intervention for Youth: A PRACTITIONER’S
GUIDE introduces a simple, quick, empirically derived tool for identifying youth at risk for
alcohol-related problems. If your organization manages the health and well-being of children
and adolescents ages 9–18 years, this Guide is for you. It has been produced in collaboration
with the American Academy of Pediatrics, clinical researchers, and health practitioners.
Substance misuse
and chronic disease
(e.g., HTN)
Substance misuse in
adolescents
Training/Presentati
NIDA/ATTC Blending Initiative - Buprenorphine Treatment for Young Adults
on
http://pubs.niaaa.nih.gov/publications/Practitioner/YouthGuide/Y
outhGuide.pdf
http://www.attcnetwork.org/explore/priorityareas/science/blendi
nginitiative/bupyoungadults/
Fetal alcohol
syndrome
prevention,
recognition,
management
Management of
Hepatitis and
Substance Use
Disorders
Website
SAMHSA's Fetal Alcohol Spectrum Disorder Center for Excellence - The FASD Center is a
http://fasdcenter.samhsa.gov/
Federal initiative devoted to preventing and treating FASD. This Website provides information
and resources about FASD. We also provide materials you can use to raise awareness about
FASD. Additionally, The Center is dedicated to providing training, technical assistance, and
conference/event speakers.
Online course
SAMHSA's FASD Center for Excellence Curriculum for Addiction Professionals (CAP): Level 1, http://fasdcenter.samhsa.gov/educationTraining/courses/CapCurr
6-module free, self-paced course. "This curriculum was developed as a joint project of the
iculum/index.cfm
Substance Abuse and Mental Health Services Administration (SAMHSA) Fetal Alcohol Spectrum
Disorders (FASD) Center for Excellence and the National Organization on Fetal Alcohol
Syndrome (NOFAS). This knowledge-based course provides an overview of historical findings
related to alcohol use by pregnant women, identification and diagnosis of fetal alcohol
spectrum disorders, prevention and treatment methods, and legal issues. The course includes
six competencies that can be taken at your own pace. After completing all six competencies,
you may download and print a certificate of completion."
Website
CDC's National Organization on Fetal Alcohol Syndrome (NOFAS) website
http://www.nofas.org/default.aspx
Booklet
CDC Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis. This report provides
diagnostic guidelines for FAS and information about referrals, services for people with FASDs
and their families, and strategies for screening and advising women about risky drinking
http://www.cdc.gov/ncbddd/fasd/documents/fas_guidelines_acc
essible.pdf
Presentation
SAMHSA's FASD Center for Excellence FASD: The Basics is an educational presentation created http://fasdcenter.samhsa.gov/educationTraining/fasdBasics.cfm
to provide the latest and most accurate information on Fetal Alcohol Spectrum Disorders
(FASD). It covers the history of FASD discovery, examines cause and effects of FASD, and
discusses the methods and resources for diagnosis, treatment and –most importantly– the
prevention of FASD.
Manual
SAMHSA's TIP 53 Addressing Viral Hepatitis in People with Substance Use Disorders Assists
behavioral health professionals who treat people with substance abuse problems in
understanding the implications of a diagnosis of hepatitis. Discusses screening, diagnosis, and
referrals and explains how to evaluate a program's hepatitis practices.
http://store.samhsa.gov/product/TIP-53-Addressing-ViralHepatitis-in-People-With-Substance-Use-Disorders/SMA11-4656